ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years
Claudio Fiorillo
Matched on ORCID iD 0000-0001-7681-3567; OpenAlex author ID A5030505593. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 3 papers · 2025: 1 paper
Papers 7
- Surgical treatment of synchronous liver-only oligometastatic pancreatic adenocarcinoma: a systematic review and meta-analysis of long-term outcomes. Co-author DOI 10.1097/js9.0000000000002338↗
- REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. Co-author DOI 10.1007/s13304-024-01860-0↗
- Minimally invasive versus open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma: an entropy balancing analysis. Co-author DOI 10.1016/j.hpb.2023.09.013↗
- REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
- The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience. Co-author DOI 10.3389/fsurg.2023.1119557↗
- Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15184586↗
- Resection margin status in pancreatic cancer surgery: is it really less important than the N status? Co-author DOI 10.1002/bjs.11356↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sergio Alfieri · 5 shared papers, 2019–2025 · strength 0.90
- Paper Surgical treatment of synchronous liver-only oligometastatic pancreatic adenocarcinoma: a systematic review and meta-an… DOI 10.1097/js9.0000000000002338↗
- Paper Minimally invasive versus open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma: an … DOI 10.1016/j.hpb.2023.09.013↗
- Paper Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers15184586↗
- Giuseppe Quero · 4 shared papers, 2019–2025 · strength 0.70
- Paper Surgical treatment of synchronous liver-only oligometastatic pancreatic adenocarcinoma: a systematic review and meta-an… DOI 10.1097/js9.0000000000002338↗
- Paper Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers15184586↗
- Paper Resection margin status in pancreatic cancer surgery: is it really less important than the N status? DOI 10.1002/bjs.11356↗
- Teresa Mezza · 1 shared paper, 2025 · strength 0.22
- Edoardo Rosso · 1 shared paper, 2024 · strength 0.20
- Emanuele F. Kauffmann · 1 shared paper, 2024 · strength 0.20
- Fabrizio Panaro · 1 shared paper, 2024 · strength 0.20
- Riccardo Casadei · 1 shared paper, 2024 · strength 0.20
- Cecilia Ferrari · 1 shared paper, 2024 · strength 0.20
- Claudio Ricci · 1 shared paper, 2024 · strength 0.20
- Alessandro Zerbi · 1 shared paper, 2024 · strength 0.20
- Ugo Boggi · 1 shared paper, 2024 · strength 0.20
- Federica Vitale · 1 shared paper, 2023 · strength 0.17
- Lorenzo Zileri Dal Verme · 1 shared paper, 2023 · strength 0.17
- Alberto Nicoletti · 1 shared paper, 2023 · strength 0.17
- Valerio Papa · 1 shared paper, 2023 · strength 0.15
- Lisa Salvatore · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.